Viewing StudyNCT00023166

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00023166
Status: TERMINATED
Last Update Posted: 2005-06-24
First Post: 2001-08-24
Brief Title: Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors Lymphomas
Sponsor: Enzon Pharmaceuticals Inc
Organization: Enzon Pharmaceuticals Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Neoplasm Metastasis
Neoplasm
Lymphomas
Keywords:
Name View
Neoplasm metastasis View
Phase I View
Open label View
Safetyefficacy View
Lymphomas View
Advanced primary andor metastatic solid tumors View
Neoplasms View